CME Group (NASDAQ:CME) Given Sell Rating at Rosenblatt Securities

CME Group (NASDAQ:CMEGet Free Report)‘s stock had its “sell” rating reissued by Rosenblatt Securities in a report issued on Thursday, Benzinga reports. They presently have a $187.00 price objective on the financial services provider’s stock, up from their prior price objective of $185.00. Rosenblatt Securities’ target price suggests a potential downside of 12.04% from the stock’s previous close.

Several other research analysts also recently commented on CME. Argus increased their price objective on CME Group from $225.00 to $245.00 and gave the company a “buy” rating in a research note on Wednesday, March 6th. The Goldman Sachs Group cut shares of CME Group from a “neutral” rating to a “sell” rating and set a $195.00 price objective for the company. in a research note on Wednesday, January 3rd. Deutsche Bank Aktiengesellschaft reissued a “hold” rating and issued a $210.00 target price (down from $235.00) on shares of CME Group in a research note on Friday, April 5th. Keefe, Bruyette & Woods reaffirmed a “market perform” rating and issued a $229.00 price target on shares of CME Group in a report on Wednesday, April 3rd. Finally, Barclays lifted their price objective on CME Group from $225.00 to $226.00 and gave the stock an “equal weight” rating in a research report on Monday, April 8th. Two analysts have rated the stock with a sell rating, seven have assigned a hold rating and two have given a buy rating to the company’s stock. According to data from MarketBeat.com, the company presently has a consensus rating of “Hold” and an average target price of $216.40.

View Our Latest Research Report on CME Group

CME Group Stock Down 1.9 %

CME stock opened at $212.59 on Thursday. CME Group has a 52 week low of $175.73 and a 52 week high of $223.80. The company has a quick ratio of 1.02, a current ratio of 1.02 and a debt-to-equity ratio of 0.13. The firm has a 50-day simple moving average of $214.73 and a 200-day simple moving average of $211.93. The stock has a market capitalization of $76.53 billion, a P/E ratio of 23.97, a P/E/G ratio of 6.09 and a beta of 0.49.

CME Group (NASDAQ:CMEGet Free Report) last posted its quarterly earnings data on Wednesday, February 14th. The financial services provider reported $2.37 EPS for the quarter, topping the consensus estimate of $2.27 by $0.10. The company had revenue of $1.44 billion during the quarter, compared to analyst estimates of $1.43 billion. CME Group had a return on equity of 12.32% and a net margin of 57.83%. CME Group’s quarterly revenue was up 19.2% on a year-over-year basis. During the same period in the previous year, the business earned $1.92 EPS. Equities analysts forecast that CME Group will post 9.58 earnings per share for the current fiscal year.

Institutional Trading of CME Group

A number of hedge funds and other institutional investors have recently modified their holdings of CME. Naples Global Advisors LLC increased its position in shares of CME Group by 5.6% during the fourth quarter. Naples Global Advisors LLC now owns 2,072 shares of the financial services provider’s stock valued at $436,000 after acquiring an additional 110 shares during the last quarter. Sapient Capital LLC acquired a new stake in CME Group in the 4th quarter valued at approximately $1,823,000. FNY Investment Advisers LLC acquired a new stake in CME Group in the 4th quarter valued at approximately $1,074,000. Deutsche Bank AG raised its position in CME Group by 4.3% in the third quarter. Deutsche Bank AG now owns 1,118,104 shares of the financial services provider’s stock valued at $223,867,000 after purchasing an additional 46,021 shares during the period. Finally, International Assets Investment Management LLC acquired a new position in CME Group during the fourth quarter worth $27,986,000. 87.75% of the stock is owned by institutional investors and hedge funds.

CME Group Company Profile

(Get Free Report)

CME Group Inc, together with its subsidiaries, operates contract markets for the trading of futures and options on futures contracts worldwide. It offers futures and options products based on interest rates, equity indexes, foreign exchange, agricultural commodities, energy, and metals, as well as fixed income and foreign currency trading services.

Read More

Analyst Recommendations for CME Group (NASDAQ:CME)

Receive News & Ratings for CME Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for CME Group and related companies with MarketBeat.com's FREE daily email newsletter.